BNTX logo

BioNTech SE (BNTX) Free Cash Flow

Annual FCF:

-$264.58M-$5.31B(-105.25%)
December 31, 2024

Summary

  • As of today, BNTX annual free cash flow is -$264.58 million, with the most recent change of -$5.31 billion (-105.25%) on December 31, 2024.
  • During the last 3 years, BNTX annual free cash flow has fallen by -$1.13 billion (-130.43%).
  • BNTX annual free cash flow is now -101.91% below its all-time high of $13.89 billion, reached on December 31, 2022.

Performance

BNTX Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXcash flow metrics

Quarterly FCF:

$785.48M+$85.44M(+12.21%)
September 30, 2025

Summary

  • As of today, BNTX quarterly free cash flow is $785.48 million, with the most recent change of +$85.44 million (+12.21%) on September 30, 2025.
  • Over the past year, BNTX quarterly free cash flow has increased by +$1.56 billion (+200.87%).
  • BNTX quarterly free cash flow is now -83.50% below its all-time high of $4.76 billion, reached on September 30, 2022.

Performance

BNTX Quarterly Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXcash flow metrics

TTM FCF:

-$588.37M+$1.56B(+72.67%)
September 30, 2025

Summary

  • As of today, BNTX TTM free cash flow is -$588.37 million, with the most recent change of +$1.56 billion (+72.67%) on September 30, 2025.
  • Over the past year, BNTX TTM free cash flow has dropped by -$2.07 billion (-139.80%).
  • BNTX TTM free cash flow is now -104.27% below its all-time high of $13.78 billion, reached on December 31, 2022.

Performance

BNTX TTM Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXcash flow metrics

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

BNTX Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-105.3%+200.9%-139.8%
3Y3 Years-130.4%-83.5%-104.5%
5Y5 Years+12.3%+427.5%-37.4%

BNTX Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-101.9%at low-83.5%+153.3%-104.3%+72.7%
5Y5-Year-101.9%+12.3%-83.5%+153.3%-104.3%+72.7%
All-TimeAll-Time-101.9%+12.3%-83.5%+153.3%-104.3%+72.7%

BNTX Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2025
-
$785.48M(+12.2%)
-$588.37M(+72.7%)
Jun 2025
-
$700.03M(+147.6%)
-$2.15B(-72.9%)
Mar 2025
-
-$1.47B(-144.7%)
-$1.25B(-368.1%)
Dec 2024
-$264.58M(-105.2%)
-$601.69M(+22.7%)
-$266.00M(-118.0%)
Sep 2024
-
-$778.73M(-148.4%)
$1.48B(-50.5%)
Jun 2024
-
$1.61B(+426.1%)
$2.99B(-48.3%)
Mar 2024
-
-$492.97M(-143.1%)
$5.78B(+5.1%)
Dec 2023
$5.04B(-63.7%)
$1.14B(+56.0%)
$5.50B(+14.6%)
Sep 2023
-
$732.32M(-83.4%)
$4.80B(-45.6%)
Jun 2023
-
$4.40B(+667.6%)
$8.83B(+3.5%)
Mar 2023
-
-$775.31M(-275.1%)
$8.53B(-38.1%)
Dec 2022
$13.89B
$442.74M(-90.7%)
$13.78B(+5.8%)
Sep 2022
-
$4.76B(+16.0%)
$13.03B(+30.0%)
Jun 2022
-
$4.10B(-8.3%)
$10.02B(+74.0%)
DateAnnualQuarterlyTTM
Mar 2022
-
$4.48B(+1529.5%)
$5.76B(+561.2%)
Dec 2021
$869.58M(+871.1%)
-$313.07M(-117.9%)
$870.50M(-38.5%)
Sep 2021
-
$1.75B(+1215.4%)
$1.42B(+346.0%)
Jun 2021
-
-$156.95M(+61.7%)
-$575.28M(-26.8%)
Mar 2021
-
-$410.13M(-277.0%)
-$453.87M(-300.7%)
Dec 2020
-$112.77M(+62.6%)
$231.66M(+196.6%)
-$113.26M(+73.6%)
Sep 2020
-
-$239.87M(-575.1%)
-$428.28M(-61.4%)
Jun 2020
-
-$35.53M(+48.9%)
-$265.36M(+10.8%)
Mar 2020
-
-$69.52M(+16.6%)
-$297.59M(+1.4%)
Dec 2019
-$301.77M(-103.0%)
-$83.36M(-8.3%)
-$301.82M(-38.2%)
Sep 2019
-
-$76.95M(-13.6%)
-$218.46M(-54.4%)
Jun 2019
-
-$67.76M(+8.1%)
-$141.51M(-91.9%)
Mar 2019
-
-$73.75M
-$73.75M
Dec 2018
-$148.69M(-19.5%)
-
-
Dec 2017
-$124.42M
-
-

FAQ

  • What is BioNTech SE annual free cash flow?
  • What is the all-time high annual free cash flow for BioNTech SE?
  • What is BioNTech SE annual free cash flow year-on-year change?
  • What is BioNTech SE quarterly free cash flow?
  • What is the all-time high quarterly free cash flow for BioNTech SE?
  • What is BioNTech SE quarterly free cash flow year-on-year change?
  • What is BioNTech SE TTM free cash flow?
  • What is the all-time high TTM free cash flow for BioNTech SE?
  • What is BioNTech SE TTM free cash flow year-on-year change?

What is BioNTech SE annual free cash flow?

The current annual free cash flow of BNTX is -$264.58M

What is the all-time high annual free cash flow for BioNTech SE?

BioNTech SE all-time high annual free cash flow is $13.89B

What is BioNTech SE annual free cash flow year-on-year change?

Over the past year, BNTX annual free cash flow has changed by -$5.31B (-105.25%)

What is BioNTech SE quarterly free cash flow?

The current quarterly free cash flow of BNTX is $785.48M

What is the all-time high quarterly free cash flow for BioNTech SE?

BioNTech SE all-time high quarterly free cash flow is $4.76B

What is BioNTech SE quarterly free cash flow year-on-year change?

Over the past year, BNTX quarterly free cash flow has changed by +$1.56B (+200.87%)

What is BioNTech SE TTM free cash flow?

The current TTM free cash flow of BNTX is -$588.37M

What is the all-time high TTM free cash flow for BioNTech SE?

BioNTech SE all-time high TTM free cash flow is $13.78B

What is BioNTech SE TTM free cash flow year-on-year change?

Over the past year, BNTX TTM free cash flow has changed by -$2.07B (-139.80%)
On this page